Showing results (491-500 of 537) with videos related to
Sort By:
Pageof 54
Leukemia|August 30, 2002
Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factorsM Oosterveld, P Muus, S Suciu, et al.Bone Marrow Transplantation|August 26, 1998
Umbilical cord blood transplant from HLA-mismatched unrelated donor in high-risk leukemiaW Arcese, A P Iori, M Screnci, et al.British Journal of Haematology|October 16, 1999
Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia. Gruppo Italiano Malattie Ematologiche Maligne dell'AdultoL Pagano, A Pulsoni, M E Tosti, et al.Indian Journal of Palliative Care|October 7, 2011
Homecare-based Motor Rehabilitation in Musculoskeletal Chronic Graft Versus Host DiseaseA Tendas, C Boschetto, L Baraldi, et al.Annals of Hematology|November 8, 2015
The impact of comorbidity on health-related quality of life in elderly patients with chronic myeloid leukemiaF Efficace, G Rosti, M Breccia, et al.La Radiologia Medica|April 22, 2011
E-learning in radiology: Italian multicentre experienceA Carriero, B Beomonte Zobel, L Bonomo, et al.Extremophiles : Life Under Extreme Conditions|May 14, 2017
Thermal adaptation strategies of the extremophile bacterium Thermus filiformis based on multi-omics analysisF Mandelli, M B Couger, D A A Paixão, et al.Leukemia|August 5, 2005
Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia GroupsS Amadori, S Suciu, R Stasi, et al.Leukemia|May 17, 2003
The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)M Oosterveld, S Suciu, G Verhoef, et al.Leukemia|September 1, 1996
Outcome of patients with acute myeloid leukemia who failed to respond to a single course of first-line induction therapy: a GIMEMA study of 218 unselected consecutive patients. Gruppo Italiano Malattie Ematologiche Maligne dell'AdultoV Liso, P Iacopino, G Avvisati, et al.Pageof 54